Medivir AB (publ)
OTC: MVRBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jens Lindberg
- Employees
- 10
- Headquarters
- Huddinge, Sweden
- IPO year
- 2010
- Market cap
- $45.8M
- Website
- https://www.medivir.com
Loading MVRBF…
Loading profile data…Frequently asked questions about MVRBF
What does Medivir AB (publ) (MVRBF) do?
Medivir AB (publ), established in 1987 and headquartered in Huddinge, Sweden, is a pharmaceutical company dedicated to the discovery, development, and commercialization of medicines, with a primary emphasis on oncology. The company's operations span both Sweden and international markets. Currently, Medivir markets Zoviduo (formerly Xerclear) for...
Where does MVRBF trade?
Medivir AB (publ) (MVRBF) trades on the Other OTC.
What sector is MVRBF in?
Medivir AB (publ) (MVRBF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Medivir AB (publ)?
Jens Lindberg is the chief executive officer of Medivir AB (publ) (MVRBF).
Where is Medivir AB (publ) headquartered?
Medivir AB (publ) is headquartered in Sweden.
Does MVRBF pay a dividend?
Medivir AB (publ) (MVRBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MVRBF go public?
Medivir AB (publ) (MVRBF) completed its initial public offering in 2010.